Full-scale commercialization of polyhydroxyalkanoate (PHA) biopolymers by Metabolix Inc., Cambridge, Mass., and joint-venture partner Archer Daniels Midland Co. (ADM), Decatur, Ill., moved a few steps closer recently with the announcement of the first commercial application.

Full-scale commercialization of polyhydroxyalkanoate (PHA) biopolymers by Metabolix Inc., Cambridge, Mass., and joint-venture partner Archer Daniels Midland Co. (ADM), Decatur, Ill., moved a few steps closer recently with the announcement of the first commercial application. The joint venture has been named Telles and the tradename for the PHA product is Mirel. Metabolix is currently making about 20,000 lb/month of PHA for market development. A 110-millionlb/yr plant in Clinton, Iowa, is expected to start up in late 2008. Grades for injection molding, sheet extrusion, and extrusion coating will be announced in about three months, according to Bob Findlen, Metabolix v.p. of sales and marketing. Initial grades of Mirel PHA will cost about $2.50/lb. The fi rst commercial application is the E-Staple "turf stakes" injection molded by American Excelsior Co., Arlington, Texas. They hold sod, netting, and silt fences for erosion control. Unlike metal, they can be left in the ground to biodegrade. Tel: (617) 492-0505 . www.metabolix.com

Metabolix, Inc.
21 Erie St. Cambridge, MA 02139-4260
Phone (617) 492-0505 Fax (617) 492-1996